Return to Home

Apellis Pharmaceuticals, Inc.

APLS

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
October 02, 2023

Days Left:
-431

calendar

Apellis Pharmaceuticals, Inc. Form












Securities Fraud News does not share your information with others. There is no cost or obligation for you to submit.

Allegations

The filed complaint alleges that defendants made false statements and/or concealed that: (1) the design of SYFOVRE’s clinical trials was insufficient to identify incidents of retinal vasculitis in patients receiving SYFOVRE injections; (2) as a result, the commercial adoption of SYFOVRE was subject to significant, unknown risk factors; and (3) therefore, defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Apellis purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Apellis during the relevant time frame, you have until October 02, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Find More Cases

Ticker Symbol Company Name Join Deadline
UPS United Parcel Service, Inc. December 09, 2024 Join
EW Edwards Lifesciences Corporation December 13, 2024 Join
TD The Toronto-Dominion Bank December 23, 2024 Join
WOLF Wolfspeed, Inc. January 17, 2025 Join